Ansem strongly dismisses Zcash (ZEC) as a viable trade, implying it's a poor investment choice. While not explicitly endorsing Celestia (TIA) or Injective (INJ), the context suggests these are considered better alternatives for current trading opportunities. Investors should avoid ZEC based on this sentiment.